T
Timothy L. Ratliff
Researcher at Purdue University
Publications - 312
Citations - 20541
Timothy L. Ratliff is an academic researcher from Purdue University. The author has contributed to research in topics: Prostate cancer & Cancer. The author has an hindex of 69, co-authored 306 publications receiving 19092 citations. Previous affiliations of Timothy L. Ratliff include University of Iowa Hospitals and Clinics & Beth Israel Deaconess Medical Center.
Papers
More filters
Journal ArticleDOI
Role of immunotherapy in the prevention of recurrence and invasion of urothelial bladder tumors: a review
Eric O. Haff,Steven M. Dresner,David R. Kelley,Timothy L. Ratliff,Amos Shapiro,William J. Catalona +5 more
TL;DR: Interferon inducer polyriboinosinic acid-polyribocytidylic and passive immunotherapy with sensitized pig lymphocytes are reviewed with emphasis on the studies of BCG as prophylaxis against and treatment for superficial transitional cell carcinoma of the bladder.
Journal ArticleDOI
Immunotherapy with Keyhole Limpet Hemocyanin: Efficacy and Safety in the MB-49 Intravesical Murine Bladder Tumor Model
Richard D. Swerdlow,Richard D. Swerdlow,Timothy L. Ratliff,Timothy L. Ratliff,Marie La Regina,Marie La Regina,Julie Ritchey,Julie Ritchey,Ray F. Ebert,Ray F. Ebert +9 more
TL;DR: The efficacy and safety of KLH-IA are established in mice and it is suggested that clinical trials for intravesical treatment of superficial bladder cancer may be warranted.
Journal ArticleDOI
Comparison of viral vectors: gene transfer efficiency and tissue specificity in a bladder cancer model.
TL;DR: The viral vectors examined resulted in significantly different gene transfer in the orthotopic bladder cancer model, underscoring the importance of vector selection in gene therapy protocols.
Cholesterol Sulfonation Enzyme, SULT2B1b, Modulates AR and Cell Growth Properties in Prostate Cancer
Renee E. Vickman,Scott A. Crist,Kevin S. Kerian,Livia S. Eberlin,R. Graham Cooks,Grant N. Burcham,Kimberly K. Buhman,Chang-Deng Hu,Andrew D. Mesecar,Liang Cheng,Timothy L. Ratliff +10 more
TL;DR: Evidence is provided that SULT2B1b is a novel regulator of AR activity and cell growth in prostate cancer and should be further investigated for therapeutic potential.
Journal ArticleDOI
Cholesterol Sulfonation Enzyme, SULT2B1b, Modulates AR and Cell Growth Properties in Prostate Cancer
Renee E. Vickman,Scott A. Crist,Kevin S. Kerian,Livia S. Eberlin,R. Graham Cooks,Grant N. Burcham,Kimberly K. Buhman,Chang-Deng Hu,Andrew D. Mesecar,Liang Cheng,Timothy L. Ratliff +10 more
TL;DR: In this paper, the authors used RNAi-mediated knockdown (KD) of SULT2B1b to assess the impact on cell growth and survival in prostate cancer.